S
Santanu Maji
Researcher at Virginia Commonwealth University
Publications - 15
Citations - 375
Santanu Maji is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 8, co-authored 13 publications receiving 212 citations. Previous affiliations of Santanu Maji include Manipal University & Nalco Holding Company.
Papers
More filters
Book ChapterDOI
Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer.
Santanu Maji,Sanjay Panda,Sabindra K. Samal,Omprakash Shriwas,Rachna Rath,Maurizio Pellecchia,Luni Emdad,Swadesh K. Das,Paul B. Fisher,Rupesh Dash +9 more
TL;DR: The potential role of B cl-2 antiapoptotic proteins in the development of cancer chemoresistance is overviewed and the clinical approaches that use Bcl-2 inhibitors to restore cell death in chemoresistant and recurrent tumors are overviewed.
Journal ArticleDOI
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas
Santanu Maji,Sabindra K. Samal,Laxmipriya Pattanaik,Swagatika Panda,Bridget A. Quinn,Swadesh K. Das,Devanand Sarkar,Maurizio Pellecchia,Paul B. Fisher,Rupesh Dash +9 more
TL;DR: It is reported for the first time that a BH3 mimetic, Sabutoclax, which functions as an inhibitor of all anti-apoptotic Bcl-2 proteins, induced cancer-specific cell death in an Mcl-1-dependent manner through both apoptosis and toxic mitophagy.
Journal ArticleDOI
STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Santanu Maji,Santanu Maji,Omprakash Shriwas,Omprakash Shriwas,Sabindra K. Samal,Sabindra K. Samal,Manashi Priyadarshini,Rachna Rath,Sanjay Panda,Saroj Kumar Das Majumdar,Dillip Kumar Muduly,Rupesh Dash +11 more
TL;DR: In patient-derived xenograft model of advanced stage and chemoresistant OSCC tumor, Triptolide restores cisplatin-mediated cell death and facilitates significant reduction of tumor burdens.
Journal ArticleDOI
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
Swadesh K. Das,Santanu Maji,Stephen L. Wechman,Praveen Bhoopathi,Anjan K. Pradhan,Sarmistha Talukdar,Devanand Sarkar,Joseph W. Landry,Chunqing Guo,Xiang-Yang Wang,Webster K. Cavenee,Luni Emdad,Paul B. Fisher +12 more
TL;DR: An overview of the metastatic process is provided and a unique pro-metastatic gene, melanoma differentiation associated gene-9/Syntenin (MDA-9) also called syndecan binding protein (SDCBP), which is a major contributor to the majority of independent metastatic events is highlighted.
Journal ArticleDOI
Good's buffer derived highly emissive carbon quantum dots: excellent biocompatible anticancer drug carrier
Aneeya K. Samantara,Aneeya K. Samantara,Santanu Maji,Arnab Ghosh,Bamaprasad Bag,Bamaprasad Bag,Rupesh Dash,Bikash Kumar Jena,Bikash Kumar Jena +8 more
TL;DR: The anticancer drug doxorubicin was successfully loaded on the CQDs and their delivery efficiency to the target cells via in vitro treatment of cancerous cells was explored, which showed a higher killing rate of the cancer cells compared to bare DOX.